ReviewClinical reviews in allergy & immunology2005

Safety and tolerability of omalizumab (Xolair), a recombinant humanized monoclonal anti-IgE antibody.

Yamo M Deniz et al.PubMed ↗Publisher ↗

No numbers read from the abstract.